A large, broadly focused meeting, New Horizons in Cancer Research: Biology to Prevention to Therapy will center on translational cancer research, drawing on the latest trends and discoveries in the early detection, prevention, and treatment of cancer. The conference will be structured to appeal to a broad spectrum of cancer researchers and clinicians. With a focus on advances in tumor biology, cancer genetics, molecular epidemiology, and novel therapeutics, the conference will pay particular attention to some of the most common cancers that occur in India, including head and neck, cervical, lung, and breast cancers. The planning and execution of this meeting will be a collaborative effort involving a number of the world’s leading cancer researchers and clinicians. Both the Program Committee and the Organizing Committee are comprised of leaders in cancer research and care from both India and the United States A robust program is being developed, which will provide significant value to those attending the conference. Conference attendance will be drawn from the academic research and clinical community, as well as industry. As such, New Horizons in Cancer Research will serve as a dynamic platform for the advancement of cancer science and care, and for the establishment of new collaborations on an international scale. We are confident that this meeting will be fertile ground for the exchange of information, ideas, and resources.